Published in Health Risk Factor Week, June 10th, 2008
"Patients with advanced non-small cell lung cancer receiving weekly docetaxel as second-or third-line treatment at a medical center between 1999 and 2003 were identified from cancer registry and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.